No products in the cart.
MedStar Health 5th Annual MedStar Heart Failure Summit 2022
+ Include: 22 videos + 1 pdf, size: 3.25 GB
+ Target Audience: cardiologist
Description
+ Include: 22 videos + 1 pdf, size: 3.25 GB
+ Target Audience: cardiologist
+ Information:
Date & Location
Saturday, November 12, 2022, 7:15 AM – 4:00 PM, Virtual: Platform- On Air, Bethesda, MD
Target Audience
Specialties – Cardiac Surgery, Cardiovascular Disease, Critical Care Medicine, Hematology, Hospice and Palliative Medicine, Internal Medicine, Medical Oncology, Palliative Medicine, Physical Medicine/ Rehabilitation, Transplant
Professions – Non-Physician, Nurse, Nurse Practitioner, Physician, Physician Assistant, Social Worker, Student
Overview
This virtual symposium will review the latest in the diagnosis and management of heart failure. A special emphasis will be given to special conditions such as structural heart disease, pulmonary hypertension, infiltrative cardiomyopathies, and cardio-oncology. It will also provide an update on recently published heart failure guidelines, an overview of modalities for treating end-stage heart failure such as mechanical circulatory support and heart transplantation. Integration of the multidisciplinary team, including palliative care, will also be discussed.
Objectives
After completing this activity, the participant will be able to:
- Implement the most recent ACC/AHA guidelines in the diagnosis and management of heart failure.
- Identify the risk factors for the development of chemotherapy-related cardiac disease and discuss current recommendations for treatment.
- Recognize special conditions in patients with heart disease including structural heart disease, pulmonary hypertension, cardio-oncology, and infiltrative diseases.
- Identify when to refer patients for specialized diagnostics and referral to advanced heart failure specialists and palliative care providers.
- Describe the most current modalities for treating end-stage heart failure including left ventricular assist devices (LVAD) and heart transplant.
- Describe the evaluation of patients with suspected infiltrative cardiomyopathy and implement newly approved pharmacologic therapy for amyloidosis.
- Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with heart failure.
- Integrate a team-based approach in the care of patients with heart failure.
+ Topics:
Keynote Introduction and Keynote Address Patient-Centered Care in Cardiac Surgery.mp4
Keynote Questions and Discussion.mp4
MHFS2022_brochure.pdf
Session 1 Introduction and Update on the Heart Failure Guidelines.mp4
Session 1 New Frontiers in Structural Heart Disease.mp4
Session 1 New Medical Therapies in Hypertrophic Cardiomyopathy.mp4
Session 1 Panel Discussion.mp4
Session 1 Ventricular Arrhythmias in Heart Failure Medical Device Catheter Therapies.mp4
Session 2 Introduction and Cardiogenic Shock.mp4
Session 2 Medical Innovation in Heart Transplantation.mp4
Session 2 Panel Discussion.mp4
Session 2 Surgical Innovation in Transplantation.mp4
Session 2 Update in Durable Left Ventricular Assist Device (LVAD) Therapy.mp4
Track IVA Introduction Multidisciplinary Care and Fundamentals of Nursing Care for the Heart Failure Patient.mp4
Track IVA Panel Discussion.mp4
Track IVA Reducing Barriers to Candidacy for AHF Therapies A Psychosocial Perspective.mp4
Track IVA Success in Heart Failure Educating the Patient, the Caregivers, and Health Care Provider.mp4
Track IVA The Difficult Discussions Advance Care Planning in Heart Failure and the Role of Palliative Care.mp4
Track IVB Amyloidosis.mp4
Track IVB ECMO and Temporary MCS for Cardiogenic Shock.mp4
Track IVB Introduction Special Considerations in Heart Failure Management and Sarcoidosis.mp4
Track IVB Panel Discussion.mp4
Track IVB Update in Pulmonary Hypertension.mp4
